Our vision is to improve the treatment of severe diseases. Working with the medicines of the future we focus on oncology.

Human Health

Human HealthOur main goal is to develop new pharmaceuticals with high versatility were there are wide-spread medical needs.

Further reading »


Animal Health

Animal HealthAnimal Health develops and improves existing medical treatments focusing on oncology.

Further reading »


The Share

Latest News

Oasmia initiates clinical Phase II study with Doxophos Vet for the treatment of canine lymphoma

February 17 2015
UPPSALA, February 17 2015. Oasmia Pharmaceutical AB announced today that the company has initiated a clinical Phase II study of Doxophos Vet for the treatment of canine lymphoma.
Further reading »

Nxt2b extends loan to Oasmia

December 30 2014
UPPSALA, December 30, 2014. Oasmia Pharmaceutical AB (publ) today announced that the investment company Nxt2b AB has extended its loan to Oasmia.
Further reading »

Publication of change in the total number of shares and votes in Oasmia

December 30 2014
Further reading »

bottom